Communiqué Archives - Insights
Skip to Content MayoACCESS MayoLINK...
Week in Review: July 16 - Insights
Top highlights include: a third dose of COVID-19 vaccine sparking debate over booster shots, rare reactions with the J&J COVID-19 vaccine, and can vaccinated people get long Covid.
Cytology: A compelling molecular testing approach - Insights
Learn more about how Mayo Clinic Laboratories is advancing the use of cytology specimens for solid tumor next-generation sequencing.
Post-Bulletin Features Dr. Bobbi Pritt's "Creepy, Dreadful, Wonderful Parasites" Blog - Insights
The Rochester Post-Bulletin recently highlighted Bobbi Pritt, M.D.'s, “Creepy, Dreadful, Wonderful Parasites” blog, which celebrated its 10-year anniversary in October with a parasite-themed art contest and giveaways.
Feb. 1986: Mayo Clinic's Year-Old Liver Transplant Program - Insights
In 1986, Mayo Clinic's year-old liver transplant program was growing to be one of the largest in the world. Take a step back to 1986 by reading this article from the February issue of Mayovox.
What Does Deliberate Practice Look Like for Me? - Insights
Justin Kreuter, M.D., discusses how he applies deliberate practice to guitar playing, pathology, knowledge, and his continuous medical education.
Communiqué takes a deep dive into how Mayo Clinic Laboratories advances patient care, research, and education through laboratory medicine. Our experts are solving the most serious and complex medical challenges for patients worldwide.
Check out how Mayo Clinic Laboratories’ digital pathology initiative integrates digital infrastructure to deliver digital workflows for patients to improve overall care.
Liver Disease Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories offers the only comprehensive testing menu for liver disease developed by clinical experts that enables health care providers to determine the underlying cause and rule out other causes for the disease.
Our serum test is the first preeclampsia-specific test that can be used to stratify patients into low- or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features.
A Test in Focus Archives - Page 9 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
A Test in Focus Archives - Page 8 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
Learn more about Mayo Clinic Laboratories’ testing to identify and monitor nicotine use as part of a patient’s nicotine-use cessation treatment plan, before anesthesia/surgery, or as part of insurance policy assessments.
Carrier Screening [Test in Focus] - Insights
Michelle Kluge, M.S., CGC, explains how Mayo Clinic Laboratories’ CYPZ assay provides accurate testing for congenital adrenal hyperplasia. Using an in-depth methodology that incorporates Sanger sequencing, MCL can provide clear answers for...
Pediatric CNS Disorder Testing - Mayo Clinic Laboratories
We offer a first-of-its-kind profile including only the antibodies that are pertinent to pediatric CNS disorders—all in one evaluation.
Improving outcomes through comprehensive controlled substance monitoring - Insights
Controlled substance testing options vary in the details they provide about patient drug use, painting an incomplete picture of usage patterns that can hinder accurate prescription monitoring and treatment outcomes. However, a new...
West Nile virus [Test in Focus] - Insights
Bobbi Pritt, M.D., discusses how Mayo Clinic Labs’ updated PCR assay for West Nile virus provides increased sensitivity to detect virus RNA in multiple sources, identifies two virus lineages, and confirms diagnosis.
Learn how our testing identifies genetic and autoimmune causes of epilepsy. Accurate diagnosis helps physicians identify potential treatment options.
Hot Topic Archives - Page 4 of 5 - Insights
Skip to Content MayoACCESS MayoLINK...
Find out how our pediatric oncology testing was designed to deliver individualized insights to confirm diagnosis and guide treatment.
MayoComplete Solid Tumor Panel - Insights
Kevin Halling, M.D., Ph.D., explains how the MayoComplete Solid Tumor panel uses next-generation sequencing to assess 514 clinically significant, cancer-related genes for genetic alterations that offer insight on treatment effectivity.
Unique pediatric evaluation targets relevant autoimmune/CNS antibodies - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' pediatric autoimmune/CNS testing can better guide the treatment of autoimmune neurological diseases in children. The tailored evaluation covers only biomarkers...
Liquid biopsy offers noninvasive DNA testing for cancer care - Insights
Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D., describe Mayo Clinic Laboratories’ liquid biopsy, which analyzes blood samples for genetic information to guide cancer treatment. The circulating tumor DNA assay uses next generation...
Angela Pickart, M.S., CGC, and Emily Lauer, M.S., CGC, explain how Mayo Clinic Laboratories' multigene panel helps identify the cause of hereditary ataxia. Precise diagnosis of this complex movement disorder helps guide patient treatment...
Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D., explain why Mayo Clinic Laboratories' gene panel is the most comprehensive test available for inherited Parkinson's disease. The new panel covers all mutations known to cause the...
Results report simplifies urine test interpretation: John Lieske, M.D. - Insights
John Lieske, M.D., explains why it's now easier for clinicians to pull information from Mayo Clinic Laboratories' supersaturation test report. An updated format summarizes complex information to help guide the treatment of kidney stones.
Breast cancer panel halves turnaround time: Wei Shen, Ph.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Wei Shen, Ph.D., explains how Mayo Clinic Laboratories' new breast cancer panel provides rapid results to guide critical decisions about treatment and screening.
Weather Preparedness: Hey, How's That Weather? - Insights
Weather always seems to be at the forefront of people's minds and discussions—especially in Minnesota. We are always commenting on needing more rain, that it’s too cold, or that a blizzard is on its way. Weather, however, is no trivial...
Learn how Mayo Clinic Laboratories testing for adrenal diseases can help physicians detect and classify adrenal disorders.
Learn more about how Mayo Clinic Laboratories helps hospital laboratories reduce costs and grow revenue.
Precision oncology therapeutics - Insights
Learn more about our personalized cancer testing that establishes patients’ genetic profiles and allows physicians to select medications that optimize therapeutic efficacy while minimizing harmful reactions.
Learn more about how direct ethanol biomarker testing at Mayo Clinic Laboratories provides heightened sensitivity and specificity to accurately assess alcohol use and alcohol use disorder.
Demyelinating neuropathies - Insights
Learn how our expert-backed testing can increase confidence when it comes to the identification of several demyelinating neuropathies.
Myeloproliferative neoplasms - Insights
Learn about our reflexive molecular testing protocols that are designed to guide proper utilization of myeloproliferative neoplasms.
Learn how Mayo Clinic Laboratories and hospitals we work with around the world balance strong financial performance and world-class patient care.
Autoimmune Epilepsy Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune epilepsy contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Find out how our hereditary cancer panels use next-generation sequencing to evaluate dozens of genes associated with cancer risk.
Identifying a precise genetic cause of hearing loss impacts clinical management. Nicole Boczek, Ph.D., and Melanie Meyer, M.S., CGC, explain how Mayo Clinic Laboratories' updated panel yields comprehensive results for optimal patient care.
Laboratory Testing of Bone Turnover Markers - Insights
In this “Hot Topic,” Alicia Algeciras-Schimnich, Ph.D., professor of laboratory medicine and pathology at Mayo Clinic, discusses the role of bone turnover markers in osteoporosis treatment as well as how to best interpret changes in bone...
Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.
Join us at the American Academy of Neurology Annual Meeting to learn about the latest in autoimmune and genetic neurology testing.
Discover cutting-edge movement disorder diagnostics at Mayo Clinic Laboratories, encompassing autoimmune and hereditary conditions.
Infectious diseases - Insights
Mayo Clinic BioPharma Diagnostics offers access to the clinical trial infectious disease testing capabilities of Mayo Clinic’s internationally renowned clinical microbiology laboratories. With more than 70 years of testing experience, our...
Modified two-tiered testing for Lyme disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., discusses the modified two-tiered testing algorithm for Lyme disease entirely based on enzyme immunoassays (EIA).
Membranous nephropathy assay: PMND1 - Insights
John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides a cost-effective approach to detecting antigens known to cause membranous nephropathy — a...
As part of Mayo Clinic’s Neuro-Oncology practice, the Division of Laboratory Genetics and Genomics tests about 50 brain tumors a week, and upwards of 1,500 brain tumors a year from all over the world.
Mayo Clinic Laboratories’ nephrology experts, pathologists, and laboratory scientists uphold the highest standards of renal laboratory care.
Check out how Mayo Clinic Laboratories’ full menu of B-cell lymphoma testing, which includes next-generation sequencing and FISH testing, can inform diagnosis and prognosis for patients.
Frozen and on Time: Rapid Margin Assessment Helps Prevent Repeat Surgeries - Insights
A breakthrough in pathology, achieved more than a century ago (allegedly on a frozen window ledge in Rochester, Minnesota) has evolved into an innovative aspect of care at Mayo Clinic. Mayo is one of the only medical centers in the United...
Lab discoveries fuel updates for autoimmune movement disorders test - Insights
Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all...